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Abstract  
Background: Close contact with children may provide cross-reactive immunity to SARs-CoV-2 due to 
more frequent prior coryzal infections from seasonal coronaviruses. Alternatively, close contact with 
children may increase risk of SARs-CoV-2 infection. We investigated whether risk of infection with 
SARs-CoV-2 and severe outcomes differed between adults living with and without children. 
Methods: Working on behalf of NHS England, we conducted a population-based cohort study using 
primary care data and pseudonymously-linked hospital and intensive care admissions, and death records, 
from patients registered in general practices representing 40% of England. Using multivariable Cox 
regression, we calculated fully-adjusted hazard ratios (HR) of outcomes from 1st February-3rd August 
2020 comparing adults living with and without children in the household. 
Findings: Among 9,157,814 adults ≤65 years, living with children 0-11 years was not associated with 
increased risks of recorded SARS-CoV-2 infection, COVID-19 related hospital or ICU admission but was 
associated with reduced risk of COVID-19 death (HR 0.75, 95%CI 0.62-0.92). Living with children aged 
12-18 years was associated with a small increased risk of recorded SARS-CoV-2 infection (HR 1.08, 
95%CI 1.03-1.13), but not associated with other COVID-19 outcomes. Living with children of any age 
was also associated with lower risk of dying from non-COVID-19 causes. Among 2,567,671 adults >65 
years there was no association between living with children and outcomes related to SARS-CoV-2. We 
observed no consistent changes in risk following school closure. 
Interpretation: For adults living with children there is no evidence of an increased risk of severe 
COVID-19 outcomes. These findings have implications for determining the benefit-harm balance of 
children attending school in the COVID-19 pandemic. 
Funding This work was supported by the Medical Research Council MR/V015737/1.  
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Research in context 
Evidence before this study 
We searched MEDLINE on 19th October 2020 for population-based epidemiological studies comparing 
the risk of SARS-CoV-2 infection and COVID-19 disease in people living with and without children. We 
searched for articles published in 2020, with abstracts available, and terms "(children or parents or 
dependants) AND (COVID or SARS-CoV-2 or coronavirus) AND (rate or hazard or odds or risk), in the 
title, abstract or keywords. 244 papers were identified for screening but none were relevant. One 
additional study in preprint was identified on medRxiv and found a reduced risk of hospitalisation for 
COVID-19 and a positive SARS-CoV-2 infection among adult healthcare workers living with children.  
 
Added value of this study 
This is the first population-based study to investigate whether the risk of recorded SARS-CoV-2 infection 
and severe outcomes from COVID-19 differ between adults living in households with and without 
school-aged children during the UK pandemic. Our findings show that for adults living with children 
there is no evidence of an increased risk of severe COVID-19 outcomes although there may be a slightly 
increased risk of recorded SARS-CoV-2 infection for working-age adults living with children aged 12 to 
18 years. Working-age adults living with children 0 to 11 years have a lower risk of death from COVID-
19 compared to adults living without children, with the effect size being comparable to their lower risk of 
death from any cause. We observed no consistent changes in risk of recorded SARS-CoV-2 infection and 
severe outcomes from COVID-19 comparing periods before and after school closure. 
 
Implications of all the available evidence 
Our results demonstrate no evidence of serious harms from COVID-19 to adults in close contact with 
children, compared to those living in households without children. This has implications for determining 
the benefit-harm balance of children attending school in the COVID-19 pandemic.  
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Background 
The role of children and adolescents in the transmission of SARS-CoV-2 is uncertain. They may have 
lower susceptibility to infection1 and are less likely to experience severe disease once infected.2 
Modelling of other respiratory tract infections such as influenza suggests that children are a major driver 
of transmission during the initial phase of an epidemic, in part due to a high frequency of social contacts.3 
However, accruing evidence suggests that for SARS-CoV-2, by contrast, lower susceptibility and 
possibly lower infectiousness among children means that they may not transmit infection more than 
adults.4 
 
A suggested mechanism for lower susceptibility or propensity to disease is cross-protection due to 
immunity derived from recent seasonal coronavirus infection.5 There are four seasonal coronaviruses 
(hCoVs) that usually cause self-limiting “common cold”-like syndromes, although hCoVs are only one 
group of viruses responsible, causing 10 to 30% of common colds in adults.6 Children experience more 
colds each year than adults, with the highest infection frequency in young children.7–9 Adults in close 
contact with children also have a higher frequency of viral respiratory infections, especially adults 
exposed to younger children and among women.10  
 
If recent hCoV infection is protective against SARS-CoV-2 infection or COVID-19, then adults living 
with children may be at a lower risk than those living without children. Conversely children may also 
introduce SARS-CoV-2 infections into their households, meaning adults living with children may 
experience an increased risk of infection and severe disease. In the face of increasing transmission in 
many countries and the need for policy decisions about school opening, quantifying the overall impact of 
living with children on the risk of SARS-CoV-2 infections and severe outcomes from COVID-19 is 
important. We therefore conducted a large cohort study using UK electronic health records (EHR) with 
linked data on household members to determine whether the risk of COVID-19 outcomes differs between 
adults living with and without school-aged children.  
 
Methods  
Database Description  
Primary care records managed by the GP software provider The Phoenix Partnership (TPP) were linked to 
Secondary Uses Service (SUS) hospital admissions, Intensive Care National Audit & Research Centre 
(ICNARC) COVID-19-related Intensive Care Unit (ICU) admissions11 and Office for National Statistics 
(ONS) mortality records through OpenSAFELY, a data analytics platform created on behalf of NHS 
England to address urgent COVID-19 research questions (https://opensafely.org). 
OpenSAFELY provides a secure software interface allowing the analysis of pseudonymized primary care 
patient records from England in near real-time within the EHR vendor’s highly secure data centre, 
avoiding the need for large volumes of potentially disclosive pseudonymized patient data to be transferred 
off-site. This, in addition to other technical and organisational controls, minimizes any risk of re-
identification. Similarly, pseudonymized datasets from other data providers are securely provided to the 
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EHR vendor and linked to the primary care data. The dataset analysed within OpenSAFELY is based on 
24 million people currently registered with GP surgeries using TPP SystmOne software. It includes 
pseudonymized data such as coded diagnoses, medications and physiological parameters. No free text 
data are included. Further details on Information Governance and Ethics can be found on page 12. 
 
 
Study Design and Population  
Our pre-specified study protocol12 and post-hoc protocol amendments (Table A1) are available. 
 
The study population included all adults aged  18 years, registered and active for  three months, in an 
English TPP general practice on 1st February 2020 (study start). We followed participants until the 
earliest of: developing the outcome of interest; deregistration from their general practice; death from any 
cause; or 3rd August 2020 which was the latest date of linked outcomes, except for hospital admissions 
which were available until 1st May 2020.  
Inclusion & Exclusion Criteria 
We required participants to have  three months of follow-up before study start to allow records to be 
updated following change of GP practice, while minimising loss of households moving home more 
frequently, potentially related to having children.  
 
The TPP-developed pseudonymised household identifier links people living at the same address 
(Supplementary Methods). We excluded people with no household identifier, and individuals living in 
care homes (derived by TPP from linking addresses matched to publicly-available Care Quality 
Commission data) or household sizes >10 individuals (possible care homes or other institutions). Finally, 
we excluded households where any individual had a missing record of sex, age, or index of multiple 
deprivation (IMD), and we excluded individuals with missing ethnicity. 
Study Measures 
Exposures 
The primary exposure was an ordered categorical variable reflecting school stages, derived using the ages 
of individuals linked by the household identifier; 1) no children under 18 years in the household, 2) any 
children 0 to 11 years of age in the household, 3) no children 0 to 11 years of age but one or more 
children aged 12 to 18 years in the household. 
Outcomes 
We included four outcomes: 1) evidence of SARS-CoV-2 infection recorded in primary care defined as a 
code indicating either a clinical diagnosis of COVID-19, a positive swab test for SARS-CoV-2, or having 
sequelae of COVID-19 (Supplementary methods); 2) hospital admission for COVID-19 defined as a 
COVID-19 ICD-10 code in the primary diagnosis field (ascertained from SUS data); 3) ICU admission 
with COVID-19 that required non-invasive or invasive respiratory support (ascertained from ICNARC 
data); and 4) COVID-19 related death defined as a COVID-19 ICD-10 code anywhere on the death 
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certificate (ascertained from ONS death certificate data). Participants were able to contribute to each 
outcome. Post hoc, to contextualise our findings, we added the outcome of non-COVID-19 death defined 
as death from any other cause on the death certificate.  
Covariates  
We used a directed-acyclic graph approach to determining covariates (Figure A4), considering 
demographics including age in years, sex, body mass index (BMI; kg/m2), smoking status, IMD, 
ethnicity, geographic area, and the total number of adults in the household. We identified chronic 
comorbidities that are associated with the risk of severe COVID-19 outcomes.13 These are defined with 
links to code lists in the Supplementary Methods, with further information about demographic covariates. 
We identified participants who were recommended to shield following the UK government’s 
identification of clinically extremely vulnerable groups.14  
 
Statistical Analysis  
Primary Model 
We analysed outcomes separately for adults aged 18-65 years, those most likely to be parents or primary 
caregivers, and also of working-age; and older adults (>65 years). We described the proportion of 
individuals within each exposure and outcome, by the covariates. We then described the rate of outcomes 
according to the presence of children, and the number of children aged 0 to 11 years, in the household. 
 
We used Cox proportional hazards modelling to determine hazard ratios (HRs) for each outcome using 
robust standard errors to account for clustering by household identifier and stratifying by geographic area 
to allow for regional variation in infection rates. We wished to adjust for illness in early adult life, which 
could have impacted the ability or decision to have children, as a confounder but were concerned about 
the accuracy of dates of onset of illness in the primary care record. Therefore, we used comorbidities at 
study start as a proxy for earlier health issues, as well as a marker of differences in current health status 
between adults living with and without children. To show the impact of this adjustment we present a 
‘demographic-adjusted model’, adjusted for sex, age using a four-knot cubic spline, IMD, BMI, smoking, 
ethnicity and total number of adults in the household; and then a ‘comorbidity-adjusted model’ with 
addition of clinical comorbidities at study start. Violations of the proportional hazards assumption were 
explored by testing for a zero slope in the scaled Schoenfeld residuals. 
 
Secondary models 
We examined possible interactions between our primary exposure and: 1) time periods from 1st February 
to 3rd April 2020 and 4th April 2020 to end of follow-up for each outcome. This period was chosen to 
allow three weeks after school closure on March 20th (except for key-worker children) for infections 
related to school transmission to progress to serious outcomes; 2) sex of the adult; and 3) probable 
shielding behaviour of the adult. 
 
We also examined a potential ‘dose-response’ effect of exposure to previous coronavirus infections by 
recategorising the number of children between 0 and 11 years as 0 (reference), one, two, and ≥three. 
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To confirm that our household identifier correctly linked parents/care-givers with children we conducted 
a similar analysis over an earlier time period (1st February 2019 to 1st February 2020) where the outcome 
was a Read code for threadworm infection, a condition where we anticipated transmission from young 
children to adults. 
 
Secondly, we repeated the comorbidity-adjusted model: 1) restricting to participants with complete BMI 
and smoking data since in the main analysis we assumed those with missing BMI to be non-obese and 
those with missing smoking information to be non-smokers; 2) using age as the underlying timescale, to 
ensure we had fully adjusted for age as a confounder; 3) requiring >12 months primary care follow-up 
prior to study start, to fully capture pre-existing comorbidities; and 4) fitting time-interactions on 
covariates where there was evidence of non-proportional hazards. 
  
Since data regarding occupation (and hence risk of SARS-CoV-2 infection) was not available, we 
conducted quantitative bias analysis to assess the potential extent of confounding from high-risk 
occupation among working-age adults. Bias-adjusted hazard ratios were calculated under a range of 
plausible assumptions regarding the association between occupation and risk of infection, and prevalence 
of high-risk occupations among those with and without children.15–18 
 
Finally, we carried out an additional post-hoc analysis using multiple imputation to address those initially 
excluded for missing ethnicity data. Five imputed datasets were created with estimated hazard ratios 
combined using Rubin’s rules.19 
 
Software and Reproducibility 
We used Python 3.8 and SQL (Server 2016 Enterprise SP2) for data management and Stata 16 for 
analysis. Analysis code is available online.20 
 
Role of the funding source  
Funders had no role in the study design, collection, analysis, and interpretation of data; in the writing of 




The final cohort included 9,157,814 adults 65 years and 2,567,671 >65 years (Figure A1). Among those 
≤65 years, 5,738,498 (63%) did not live with children, 2,568,901 (28%) lived with children 0 to 11 years 
and 9% (850,415) lived with children 12 to 18 years (Table 1). A total of 29,863 (0.33%) had evidence of 
SARS-CoV-2 infection recorded in their primary care record, 4,776 (0.05%) were admitted to hospital 
with COVID-19, 1,471 (0.02%) were admitted to ICU for ventilatory support with COVID-19 and 1,173 
(0.01%) died of COVID-19 (Table A2). Those living with children were more likely to be younger, 
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female, of non-white ethnicity, have a lower IMD, have more adults in the household and have fewer 
comorbidities.   
  
Among those >65 years, 2,481,210 (97%) did not live with children (Table 2). A total of 11,826 (0.46%) 
had evidence of SARS-CoV-2 infection recorded in their primary care record, 6,496 (0.25%) were 
admitted to hospital with COVID-19, 675 (0.03%) were admitted to ICU for ventilatory support with 
COVID-19 and 6,352 (0.25%) died of COVID-19 (Table A3).  
Among adults ≤65 years, after adjusting for ethnicity, IMD, BMI, smoking and total number of adults in 
the household, living with children aged 0 to 11 years was not associated with recorded SARS-CoV-2 
infection, COVID-19 related hospital or ICU admission but was associated with a reduced risk of death 
from COVID-19 (HR 0.74, 95%CI 0.60-0.90) (Table A4). Living with children aged 12 to 18 years was 
associated with a small increased risk of recorded SARS-CoV-2 infection (HR 1.08, 95%CI 1.03-1.13), 
but was not associated with COVID-19 related hospital or ICU admission, or death from COVID-19 
(Table A4).  
For adults >65 years living in a household with children, there was no evidence of an association with any 
outcome (Table A4). 
Living with children of any age was associated with around 30% reduced risk of death from non-COVID-
19 causes for adults ≤65 but there was no reduction in risk for adults >65 years (Table A4). 
In all analyses, additionally adjusting for comorbidities did not materially change the results (Figure 1, 
Table A4). 
 
There were no evident trends in the associations between risks of recorded SARS-CoV-2 in primary care 
or severe outcomes from COVID-19 and the number of children aged 0 to 11 years in a household, for 
adults of any age (Table A4).    
 
We explored whether the association between household exposure to children and the risk of COVID-19 
disease varied by sex, time period in relation to school closure, and probable shielding status, in the 
comorbidity-adjusted model (Figure 2 for adults ≤65 years and Supplementary Figure A5 for adults >65 
years).  
 
Among ≤65 year olds, there was some evidence that the associations varied by sex of the adult: for 
recorded SARS-CoV-2 infection (P-value for interaction=<0.001), the small increased risk among those 
living with children aged 0 to 11 years was observed in males (HR 1.09, 95% CI 1.04-1.13) but not 
females (HR 0.99, 95%CI 0.96-1.03). For COVID-19-related hospital admission (P int=<0.001), there 
was evidence of an increased risk of admission among males living with children aged 12 to 18 years (HR 
1.24, 95%CI 1.10-1.40), but not females (HR 0.88, 95% CI 0.76-1.03).  For death from COVID-19 there 
was evidence of a reduced risk in females (HR 0.58, 95%CI 0.41-0.82 for females living with children 0 
to 11 years (P int=0.059); HR 0.57, 95% CI 0.36-0.89 (P int=0.029) for those living with children 12 to 
18 years), but no evidence of lower risk for males living with children.  
 
There was evidence that for working-age adults, the risk of recorded SARS-CoV-2 infection was higher 
in the period three weeks after school closures compared to earlier but no evidence of important variations 
in the risk of any other COVID-19 outcomes between these time periods. There was no evidence of 
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important increases in risk for any outcome for working-age adults who were likely to have been 
shielding and no evidence of any interactions for those aged >65 years.  
 
Model checking and sensitivity analyses 
Among adults ≤65 years, living with children aged 0 to 11 years was associated with a 2-fold increased 
risk of being diagnosed with threadworm (HR 2.53, 95%CI 2.19-2.92), with strong evidence of an 
increased risk with increasing number of children in the household, and an increased risk among adults 
living with children aged 12 to 18 years, though of a smaller magnitude (HR 1.32, 95%CI 1.03-1.70) 
(Table A4). 
None of the sensitivity analyses materially altered the results from the comorbidity adjusted models 
(Figure A3). 
When accounting for missing ethnicity data through multiple imputation, the associations between living 
with children and outcomes remained the same as the primary (complete case) analysis (Table A6). 
Quantitative bias analysis accounting for shared risk of people with young children working in 
occupations with high-risk of exposure did not materially alter any results (Tables A7-A14).  
Discussion 
We observed no increased risk of recorded infection or serious COVID-19 outcomes among working-age 
adults sharing a household with children aged 0 to 11 years, compared to those living without children, 
but a reduced risk of death from COVID-19. This was similar in magnitude to the reduction in risk of 
death from causes other than COVID-19 seen in working-age adults living with children of all ages. For 
working-age adults living with children aged 12 to 18 years we found a small (between three and 13%) 
increased risk of recorded SARS-CoV-2 infection, but no association with other outcomes from COVID-
19. We found no association with the risk of recorded SARS-CoV-2 infection and outcomes from 
COVID-19 among adults over 65 years living with children of any age.  
 
Our analysis has a number of important strengths. Firstly, our study is large, providing us with sufficient 
power to examine rarer outcomes, as well as interactions with several important factors. Secondly we 
show largely consistent results across SARS-CoV-2 infection and COVID-19 related clinical outcomes, 
supporting our findings. Thirdly, in our control analysis of threadworm infection in adults we show strong 
evidence that our model can detect an infection transmitted from children to adults, with, as we would 
anticipate, risk increasing with the number of children in a household and a stronger effect seen in 
younger children.  
 
However, there are also limitations. During the period covered by this study, the outcome of recorded 
SARS-CoV-2 infection is mainly based on swab tests taken in community testing centres and healthcare 
settings that were later transferred to the primary care record. Therefore, results related to testing should 
be viewed as likely to be heavily influenced by people in high-risk jobs where testing was more easily 
available. A positive recorded infection combines the risk of being infected with the chance of being 
tested and this is particularly important for interpreting the interaction by date. Occupation was also an 
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unmeasured confounder both in terms of exposure to SARS-CoV-2 (such as healthcare and other high-
risk workers) and degree of contact with children outside the home (such as nursery workers). To explore 
the potential impact of lack of occupational information we conducted a quantitative bias analysis which 
did not meaningfully change our results for any outcome. We were not able to adjust for confounding by 
previous comorbidities that affected ability or choice to have children, and subsequent risk of 
development of severe outcomes from COVID-19. However, to examine the potential impact of this we 
show results from models with and without adjusting for baseline comorbidities and again find no 
important differences. It is likely we have misclassified the degree of contact with children in a number of 
situations such as for divorced parents, and limitations in the data may mean misclassification of the 
number of people living in a household, e.g. for flats within a larger property or when people have not 
updated their address with their general practice following a house move. Finally, in this analysis we are 
assuming a constant relationship for infections between people through clustering at the household level, 
rather than detailed modelling of how infections are transmitted within households. 
 
One previous cohort study of 310,097 healthcare workers and other adults in their household in Scotland 
has also addressed whether the risk of SARS-CoV-2 infection and severe outcomes from COVID-19 
differs between adults living in households with and without children aged 0 to 11 years.21 Similar to our 
results they find no increase in hospitalisation due to COVID-19 for people living with young children. 
However, they find a slightly reduced rate of testing positive for COVID-19 for adults living with young 
children, and evidence that the protective effect increased with a greater number of children. Differences 
in power, greater consistency in testing patterns and exposure risk among healthcare workers in their 
cohort and different epidemic trajectories between Scotland and England make direct comparisons 
between our results difficult.  
 
Our findings of no increase in risk of severe outcomes from COVID-19 despite some evidence of a small 
increased risk of infection among adults living with older children could be explained by confounding if 
parents are healthier than people without children. This explanation is supported by our finding of a 
substantially lower risk of mortality from causes other than COVID-19 among working-age adults living 
with children of any age. Parents are known to have lower all-cause mortality than individuals without 
children.22,23 The protective mechanisms of having children are likely to be multifactorial, including 
healthier behaviours among parents, e.g. in relation to smoking and alcohol,24,25 and self-selection of 
healthier individuals becoming parents.26 However, beneficial changes in immune function from exposure 
to young children have been proposed to cause reduced mortality among parents.27  
 
In terms of implications for health policy, our results can be viewed as the cumulative effects of 
transmission risk of SARS-CoV-2, the impact of any cross-reactive immunity and differences in 
underlying health status and health related behaviours of adults living with and without children. We 
found that outcomes differed by the sex of the adult, with in general, less risk of severe outcomes and 
lower risk of death for women compared to men, particularly those living with younger children. Given 
that women and parents of younger children have higher rates of respiratory tract infections,10 this offers 
some clinical support to the basic science evidence that exposure to other hCoVs may offer some 
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immunity to SARS-CoV-2.28 If confirmed, this would have important implications for understanding 
high-risk populations and the likely future course of the pandemic.  
 
Concern that children act as an important source of spread of SARS-CoV-2 have led to school closures in 
many countries during the pandemic. We saw an increased risk of recorded SARS-CoV-2 infection for 
adults living with children in the period from three weeks after schools closed, compared to previously, 
although this must be interpreted in light of limitations of testing data. However, overall our findings 
suggest that on a population level transmission from school age children does not result in an increased 
risk of serious outcomes among the adults they live with.  
Conclusion 
During a period covering the first peak of the UK pandemic of SARS-CoV-2 we found no evidence of 
increased risk of serious outcomes from COVID-19 among adults of any age living with children 
compared to those in households without children. Within the limitations of testing data there was 
evidence of a small increased risk of recorded SARS-CoV-2 infection for adults living with older 
children. We found no evidence for a reduction in risk following school closure. These findings, in 
consideration alongside other evidence, have implications for determining the benefit-harm balance of 
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Table 1. Cohort description, of adults 65 years and under, by presence of children or young people in the 
household  
 Total cohort, n (%) 
No children under 18 
years in the 
household  
(column %) 
Children aged 0-11 years in 
the household  
(column %) 
Children aged ≥12 years 
in the household  
(column %) 
Total 9157814 (100.0) 5738498 (100.00) 2568901 (100.00) 850415 (100.00) 
Age     
18-<30 1947216 (21.3) 1339507 (23.34) 447691 (17.43) 160018 (18.82) 
30-<40 2202357 (24.0) 1008794 (17.58) 1105180 (43.02) 88383 (10.39) 
40-<50 1991653 (21.7) 877932 (15.30) 778576 (30.31) 335145 (39.41) 
50-<60 2012258 (22.0) 1581524 (27.56) 188351 (7.33) 242383 (28.50) 
60-<66 1004330 (11.0) 930741 (16.22) 49103 (1.91) 24486 (2.88) 
Sex     
Female 4714908 (51.5) 2778251 (48.41) 1468018 (57.15) 468639 (55.11) 
Male 4442906 (48.5) 2960247 (51.59) 1100883 (42.85) 381776 (44.89) 
BMI (kg/m2)     
<18.5 178486 (1.9) 119297 (2.08) 46178 (1.80) 13011 (1.53) 
18.5-24.9 2843580 (31.1) 1791862 (31.23) 819925 (31.92) 231793 (27.26) 
25-29.9 2497554 (27.3) 1545999 (26.94) 717998 (27.95) 233557 (27.46) 
30-34.9 (Obese class I) 1252559 (13.7) 787144 (13.72) 343727 (13.38) 121688 (14.31) 
35-39.9 (Obese class II) 505136 (5.5) 319669 (5.57) 136592 (5.32) 48875 (5.75) 
≥40 (Obese class III) 270158 (3.0) 173390 (3.02) 70850 (2.76) 25918 (3.05) 
Missing 1610341 (17.6) 1001137 (17.45) 433631 (16.88) 175573 (20.65) 
Smoking     
Never 4405852 (48.1) 2757196 (48.05) 1234664 (48.06) 413992 (48.68) 
Former 2636324 (28.8) 1629388 (28.39) 760180 (29.59) 246756 (29.02) 
Current 1869068 (20.4) 1208623 (21.06) 510614 (19.88) 149831 (17.62) 
Missing 246570 (2.7) 143291 (2.50) 63443 (2.47) 39836 (4.68) 
Ethnicity     
White 7569454 (82.7) 4901365 (85.41) 1986318 (77.32) 681771 (80.17) 
Mixed 158349 (1.7) 94318 (1.64) 49785 (1.94) 14246 (1.68) 
South Asian 832720 (9.1) 393138 (6.85) 340500 (13.25) 99082 (11.65) 
Black 306539 (3.3) 166789 (2.91) 106666 (4.15) 33084 (3.89) 
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted November 2, 2020. ; https://doi.org/10.1101/2020.11.01.20222315doi: medRxiv preprint 
17 
Other 290752 (3.2) 182888 (3.19) 85632 (3.33) 22232 (2.61) 
IMD quintile     
1 (least deprived) 1684917 (18.4) 1033896 (18.02) 470250 (18.31) 180771 (21.26) 
2 1805617 (19.7) 1165046 (20.30) 473081 (18.42) 167490 (19.70) 
3 1874964 (20.5) 1219743 (21.26) 491526 (19.13) 163695 (19.25) 
4 1976632 (21.6) 1250521 (21.79) 554876 (21.60) 171235 (20.14) 
5 (most deprived) 1815684 (19.8) 1069292 (18.63) 579168 (22.55) 167224 (19.66) 
Total number adults in 
household 
    
1 2226830 (24.3) 1750754 (30.51) 376825 (14.67) 99251 (11.67) 
2 3779868 (41.3) 2013500 (35.09) 1421964 (55.35) 344404 (40.50) 
3 3151116 (34.4) 1974244 (34.40) 770112 (29.98) 406760 (47.83) 
Blood pressure     
Normal 2440215 (26.6) 1347688 (23.49) 866256 (33.72) 226271 (26.61) 
Elevated 1324098 (14.5) 814512 (14.19) 390162 (15.19) 119424 (14.04) 
High Stage 1 2878905 (31.4) 1844169 (32.14) 759199 (29.55) 275537 (32.40) 
High Stage 2 1549272 (16.9) 1082545 (18.86) 320825 (12.49) 145902 (17.16) 
Missing 965324 (10.5) 649584 (11.32) 232459 (9.05) 83281 (9.79) 
High bp or diagnosed 
hypertension 
2156211 (23.5) 1548682 (26.99) 409471 (15.94) 198058 (23.29) 
Comorbidities     
Chronic respiratory disease ex 
asthma 
184872 (2.0) 150741 (2.63) 21629 (0.84) 12502 (1.47) 
Asthma 1574912 (17.2) 977849 (17.04) 448542 (17.46) 148521 (17.46) 
Chronic cardiac disease 259057 (2.8) 203191 (3.54) 35929 (1.40) 19937 (2.34) 
Diabetes     
No diabetes 8712703 (95.1) 5412597 (94.32) 2489806 (96.92) 810300 (95.28) 
Type 1, controlled 12483 (0.1) 8459 (0.15) 3089 (0.12) 935 (0.11) 
Type 1, uncontrolled 37382 (0.4) 25807 (0.45) 8412 (0.33) 3163 (0.37) 
Type 2, controlled 219161 (2.4) 162903 (2.84) 36861 (1.43) 19397 (2.28) 
Type 2, uncontrolled 171932 (1.9) 126000 (2.20) 29659 (1.15) 16273 (1.91) 
Diabetes, no HbA1c 4153 (0.0) 2732 (0.05) 1074 (0.04) 347 (0.04) 
Haematological cancer      
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Diagnosed < 1 year ago 2349 (0.0) 1733 (0.03) 420 (0.02) 196 (0.02) 
Diagnosed 1-4.9 years ago 7332 (0.1) 5538 (0.10) 1211 (0.05) 583 (0.07) 
Diagnosed ≥5 years ago 19225 (0.2) 14017 (0.24) 3595 (0.14) 1613 (0.19) 
Non-haematological 
cancer 
    
Diagnosed < 1 year ago 22171 (0.2) 16737 (0.29) 3454 (0.13) 1980 (0.23) 
Diagnosed 1-4.9 years ago 64176 (0.7) 48734 (0.85) 9648 (0.38) 5794 (0.68) 
Diagnosed ≥5 years ago 113243 (1.2) 89421 (1.56) 14406 (0.56) 9416 (1.11) 
Reduced kidney function     
Estimated GFR 30-60 93017 (1.0) 77514 (1.35) 9300 (0.36) 6203 (0.73) 
Estimated GFR <30 9067 (0.1) 7063 (0.12) 1298 (0.05) 706 (0.08) 
End-stage renal disease* 10815 (0.1) 8153 (0.14) 1827 (0.07) 835 (0.10) 
Chronic Liver disease 51404 (0.6) 39107 (0.68) 8860 (0.34) 3437 (0.40) 
Stroke/dementia 71425 (0.8) 57346 (1.00) 9030 (0.35) 5049 (0.59) 
Other neurological disease 63572 (0.7) 48570 (0.85) 9977 (0.39) 5025 (0.59) 
Solid organ transplant** 2103 (0.0) 1612 (0.03) 317 (0.01) 174 (0.02) 
Asplenia 10867 (0.1) 7818 (0.14) 2080 (0.08) 969 (0.11) 
Rheumatoid/Lupus/ Psoriasis 409631 (4.5) 265742 (4.63) 104306 (4.06) 39583 (4.65) 
Other immunosuppressive 
condition 
32745 (0.4) 22907 (0.40) 7280 (0.28) 2558 (0.30) 
Probable shielding*** 1922340 (21.0) 1248677 (21.76) 497917 (19.38) 175746 (20.67) 
Any comorbidity**** 2747911 (30.0) 1824629 (31.80) 671397 (26.14) 251885 (29.62) 
*End-stage renal disease includes on dialysis or having had a kidney transplant 
**All solid organ transplants, excluding kidney 
***Shielding includes organ transplant recipients, renal replacement therapy, haematological cancers, non-haematological cancers, 
immunodeficiencies/asplenia and severe respiratory conditions. 
****Any comorbidity includes: chronic respiratory disease, asthma, chronic cardiac disease, diabetes, cancer, end-stage renal disease, chronic 
liver disease, stroke or dementia, other neurological disease, other transplant, asplenia, Rheumatoid/Lupus/ Psoriasis or other immunosuppressive 
condition 
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Table 2. Cohort description, of adults over 65 years, by presence of children or young people in the household  
 
 Total cohort, n (%) 
No children under 18 
years in the household  
(column %) 
Children aged 0-11 years in 
the household  
(column %) 
Children aged ≥12 years in the 
household  
(column %) 
Total 2567671 (100.0) 2481210 (100.00) 58165 (100.00) 28296 (100.00) 
Age     
>65-70 609634 (23.7) 578189 (23.30) 22682 (39.00) 8763 (30.97) 
70-80 1300326 (50.6) 1258494 (50.72) 27598 (47.45) 14234 (50.30) 
80+ 657711 (25.6) 644527 (25.98) 7885 (13.56) 5299 (18.73) 
Sex     
Female 1384514 (53.9) 1338333 (53.94) 31332 (53.87) 14849 (52.48) 
Male 1183157 (46.1) 1142877 (46.06) 26833 (46.13) 13447 (47.52) 
BMI (kg/m2)     
<18.5 44163 (1.7) 42958 (1.73) 789 (1.36) 416 (1.47) 
18.5-24.9 760180 (29.6) 738360 (29.76) 14883 (25.59) 6937 (24.52) 
25-29.9 949715 (37.0) 919015 (37.04) 20418 (35.10) 10282 (36.34) 
30-34.9 (Obese class I) 462119 (18.0) 445225 (17.94) 11400 (19.60) 5494 (19.42) 
35-39.9 (Obese class II) 151009 (5.9) 145127 (5.85) 3854 (6.63) 2028 (7.17) 
≥40 (Obese class III) 58570 (2.3) 56065 (2.26) 1681 (2.89) 824 (2.91) 
Missing 141915 (5.5) 134460 (5.42) 5140 (8.84) 2315 (8.18) 
Smoking     
Never 1011539 (39.4) 969700 (39.08) 29086 (50.01) 12753 (45.07) 
Former 1336686 (52.1) 1301772 (52.47) 22475 (38.64) 12439 (43.96) 
Current 213854 (8.3) 205070 (8.26) 5893 (10.13) 2891 (10.22) 
Missing 5592 (0.2) 4668 (0.19) 711 (1.22) 213 (0.75) 
Ethnicity     
White 2419165 (94.2) 2362620 (95.22) 36022 (61.93) 20523 (72.53) 
Mixed 9797 (0.4) 8670 (0.35) 760 (1.31) 367 (1.30) 
South Asian 90017 (3.5) 67805 (2.73) 16729 (28.76) 5483 (19.38) 
Black 27290 (1.1) 23616 (0.95) 2531 (4.35) 1143 (4.04) 
Other 21402 (0.8) 18499 (0.75) 2123 (3.65) 780 (2.76) 
IMD quintile     
1 (least deprived) 618192 (24.1) 602937 (24.30) 9811 (16.87) 5444 (19.24) 
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted November 2, 2020. ; https://doi.org/10.1101/2020.11.01.20222315doi: medRxiv preprint 
20 
2 596748 (23.2) 580549 (23.40) 10773 (18.52) 5426 (19.18) 
3 548147 (21.3) 530203 (21.37) 11944 (20.53) 6000 (21.20) 
4 460588 (17.9) 441284 (17.79) 13271 (22.82) 6033 (21.32) 
5 (most deprived) 343996 (13.4) 326237 (13.15) 12366 (21.26) 5393 (19.06) 
Total number adults in 
household 
    
1 877922 (34.2) 874751 (35.26) 1663 (2.86) 1508 (5.33) 
2 1319765 (51.4) 1303437 (52.53) 9341 (16.06) 6987 (24.69) 
3 369984 (14.4) 303022 (12.21) 47161 (81.08) 19801 (69.98) 
Blood pressure     
Normal 298019 (11.6) 287358 (11.58) 7296 (12.54) 3365 (11.89) 
Elevated 400138 (15.6) 386920 (15.59) 8935 (15.36) 4283 (15.14) 
High Stage 1 947144 (36.9) 915718 (36.91) 21174 (36.40) 10252 (36.23) 
High Stage 2 909480 (35.4) 880644 (35.49) 18968 (32.61) 9868 (34.87) 
Missing 12890 (0.5) 10570 (0.43) 1792 (3.08) 528 (1.87) 
High bp or diagnosed 
hypertension 
1769252 (68.9) 1711606 (68.98) 38244 (65.75) 19402 (68.57) 
Comorbidities     
Chronic respiratory disease ex 
asthma 
317732 (12.4) 308239 (12.42) 6048 (10.40) 3445 (12.17) 
Asthma 347416 (13.5) 334967 (13.50) 8395 (14.43) 4054 (14.33) 
Chronic cardiac disease 536239 (20.9) 518877 (20.91) 11355 (19.52) 6007 (21.23) 
Diabetes     
No diabetes 2103299 (81.9) 2040001 (82.22) 42106 (72.39) 21192 (74.89) 
Type 1, controlled 3270 (0.1) 3174 (0.13) 62 (0.11) 34 (0.12) 
Type 1, uncontrolled 6772 (0.3) 6580 (0.27) 119 (0.20) 73 (0.26) 
Type 2, controlled 311147 (12.1) 296882 (11.97) 9798 (16.85) 4467 (15.79) 
Type 2, uncontrolled 141345 (5.5) 132921 (5.36) 5944 (10.22) 2480 (8.76) 
Diabetes, no HbA1c 1838 (0.1) 1652 (0.07) 136 (0.23) 50 (0.18) 
Haematological cancer      
Diagnosed < 1 year ago 3661 (0.1) 3563 (0.14) 62 (0.11) 36 (0.13) 
Diagnosed 1-4.9 years ago 11073 (0.4) 10776 (0.43) 189 (0.32) 108 (0.38) 
Diagnosed ≥5 years ago 22672 (0.9) 22089 (0.89) 387 (0.67) 196 (0.69) 
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Diagnosed < 1 year ago 30875 (1.2) 30042 (1.21) 557 (0.96) 276 (0.98) 
Diagnosed 1-4.9 years ago 91267 (3.6) 88872 (3.58) 1578 (2.71) 817 (2.89) 
Diagnosed ≥5 years ago 243542 (9.5) 238178 (9.60) 3378 (5.81) 1986 (7.02) 
Reduced kidney function     
Estimated GFR 30-60 535850 (20.9) 521234 (21.01) 9334 (16.05) 5282 (18.67) 
Estimated GFR <30 39509 (1.5) 38103 (1.54) 939 (1.61) 467 (1.65) 
End-stage renal disease* 6279 (0.2) 5922 (0.24) 249 (0.43) 108 (0.38) 
Chronic Liver disease 24604 (1.0) 23696 (0.96) 609 (1.05) 299 (1.06) 
Stroke/dementia 187946 (7.3) 182242 (7.34) 3733 (6.42) 1971 (6.97) 
Other neurological disease 50577 (2.0) 49058 (1.98) 1018 (1.75) 501 (1.77) 
Solid organ transplant** 825 (0.0) 774 (0.03) 34 (0.06) 17 (0.06) 
Asplenia 6355 (0.2) 6190 (0.25) 99 (0.17) 66 (0.23) 
Rheumatoid/Lupus/ Psoriasis 199014 (7.8) 193236 (7.79) 3755 (6.46) 2023 (7.15) 
Other immunosuppressive 
condition 
5235 (0.2) 5030 (0.20) 135 (0.23) 70 (0.25) 
Probable shielding*** 903291 (35.2) 876412 (35.32) 17581 (30.23) 9298 (32.86) 
Any comorbidity**** 1554606 (60.5) 1502301 (60.55) 34800 (59.83) 17505 (61.86) 
*End-stage renal disease includes on dialysis or having had a kidney transplant 
**All solid organ transplants, excluding kidney 
***Shielding includes organ transplant recipients, renal replacement therapy, haematological cancers, non-haematological cancers, 
immunodeficiencies/asplenia and severe respiratory conditions. 
*End-stage renal disease includes on dialysis or having had a kidney transplant 
**All solid organ transplants, excluding kidney 
***Shielding includes organ transplant recipients, renal replacement therapy, haematological cancers, non-haematological cancers, 
immunodeficiencies/asplenia and severe respiratory conditions. 
****Any comorbidity includes: chronic respiratory disease, asthma, chronic cardiac disease, diabetes, cancer, end-stage renal disease, chronic 
liver disease, stroke or dementia, other neurological disease, other transplant, asplenia, Rheumatoid/Lupus/ Psoriasis or other immunosuppressive 
condition 
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Figure 1: Adjusted* Hazard Ratios (HRs) for outcomes ((a) recorded SARS-CoV-2 infection, (b) COVID-19 
hospital admission, (c) COVID-19 ICU admission, (d) COVID-19 death and (e) non-COVID-19 death), 
stratified by age. 
 
Adults 65 years and under 
 
 
Adults over 65 years 
 
*Comorbidity-adjusted model: Adjusted for age, sex, ethnicity, number adults in household, IMD, BMI, smoking, hypertension or high blood pressure, chronic 
respiratory disease, asthma, cancer, chronic liver disease, stroke or dementia, other neurological disease, reduced kidney function, end-stage renal disease, solid organ 
transplant, asplenia, rheumatoid, lupus or psoriasis, other immunosuppressive condition.  
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Figure 2. Comorbidity adjusted hazard ratios (HRs) and 95% confidence intervals (CI) for each COVID-19 
outcome, compared to having no children in the household by (a) sex, (b) time periods before and after 3rd 





(b) Time periods before and on/after 3rd April 2020  
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(c) Shielding status 
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